Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6582938rdf:typepubmed:Citationlld:pubmed
pubmed-article:6582938lifeskim:mentionsumls-concept:C1705597lld:lifeskim
pubmed-article:6582938lifeskim:mentionsumls-concept:C0679133lld:lifeskim
pubmed-article:6582938lifeskim:mentionsumls-concept:C0029016lld:lifeskim
pubmed-article:6582938lifeskim:mentionsumls-concept:C0023473lld:lifeskim
pubmed-article:6582938lifeskim:mentionsumls-concept:C0008643lld:lifeskim
pubmed-article:6582938lifeskim:mentionsumls-concept:C0008665lld:lifeskim
pubmed-article:6582938lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:6582938lifeskim:mentionsumls-concept:C1283195lld:lifeskim
pubmed-article:6582938pubmed:issue12lld:pubmed
pubmed-article:6582938pubmed:dateCreated1984-4-2lld:pubmed
pubmed-article:6582938pubmed:abstractTextChronic myeloid leukaemia (CML) cells are often characterized by the presence of a small chromosome 22, in which most of the q arm has been translocated to chromosome 9. Using cell hybrids containing different parts of chromosome 22 I have mapped the c-sis oncogene, which is known to be situated on chromosome 22, to a region distal to the CML breakpoint (22q112) and proximal to 22q13. This demonstrates that c-sis is translocated to chromosome 9 in CML cells.lld:pubmed
pubmed-article:6582938pubmed:languageenglld:pubmed
pubmed-article:6582938pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6582938pubmed:citationSubsetIMlld:pubmed
pubmed-article:6582938pubmed:statusMEDLINElld:pubmed
pubmed-article:6582938pubmed:monthDeclld:pubmed
pubmed-article:6582938pubmed:issn0144-8463lld:pubmed
pubmed-article:6582938pubmed:authorpubmed-author:GoynsM HMHlld:pubmed
pubmed-article:6582938pubmed:issnTypePrintlld:pubmed
pubmed-article:6582938pubmed:volume3lld:pubmed
pubmed-article:6582938pubmed:ownerNLMlld:pubmed
pubmed-article:6582938pubmed:authorsCompleteYlld:pubmed
pubmed-article:6582938pubmed:pagination1107-11lld:pubmed
pubmed-article:6582938pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6582938pubmed:meshHeadingpubmed-meshheading:6582938-...lld:pubmed
pubmed-article:6582938pubmed:meshHeadingpubmed-meshheading:6582938-...lld:pubmed
pubmed-article:6582938pubmed:meshHeadingpubmed-meshheading:6582938-...lld:pubmed
pubmed-article:6582938pubmed:meshHeadingpubmed-meshheading:6582938-...lld:pubmed
pubmed-article:6582938pubmed:meshHeadingpubmed-meshheading:6582938-...lld:pubmed
pubmed-article:6582938pubmed:meshHeadingpubmed-meshheading:6582938-...lld:pubmed
pubmed-article:6582938pubmed:meshHeadingpubmed-meshheading:6582938-...lld:pubmed
pubmed-article:6582938pubmed:meshHeadingpubmed-meshheading:6582938-...lld:pubmed
pubmed-article:6582938pubmed:meshHeadingpubmed-meshheading:6582938-...lld:pubmed
pubmed-article:6582938pubmed:meshHeadingpubmed-meshheading:6582938-...lld:pubmed
pubmed-article:6582938pubmed:meshHeadingpubmed-meshheading:6582938-...lld:pubmed
pubmed-article:6582938pubmed:meshHeadingpubmed-meshheading:6582938-...lld:pubmed
pubmed-article:6582938pubmed:year1983lld:pubmed
pubmed-article:6582938pubmed:articleTitleMapping of the c-sis oncogene on human chromosome 22 with respect to the breakpoint associated with chronic myeloid leukaemia.lld:pubmed
pubmed-article:6582938pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6582938pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6582938lld:pubmed